To the Editor: We appreciate the thoughtful responses by our colleagues, Drs. Chaitin and Sachdev, to our editorial. We believe that the "new neuropsychiatry," with the enlarged purview that "preserve[s] the uniqueness of psychiatry and the unfolding of neuroscience," welcomed by Dr. Chaitin has already emerged and has been gaining momentum over the past decade. In our opinion, the new neuropsychiatry currently is best manifested by the members and scientific programs of the vibrant and growing American Neuropsychiatric Association. Increasingly, the younger members of the American Neuropsychiatric Association are psychiatrists and neurologists who have had 2 years of subspecialty training in neuropsychiatry or behavioral neurology after completing their respective residencies. The clinical and research foci of most members of the American Neuropsychiatric Association coincide closely with the middle path of clinical neuropsychiatry advocated by Dr. Sachdev.